RBARC²: Biphasic Apoptotic-Regenerative Reprogramming Based on Cannabinoids and Medusoid Coding

This project proposes a dual-phase theoretical cancer therapy. Phase 1 involves selective apoptosis of malignant cells via THC (targeting CB1/CB2 receptors). Phase 2 introduces a reprogramming strategy using gene pathways from the immortal jellyfish *Turritopsis dohrnii*, focused on FOXO, PI3K, and Wnt signaling to restore damaged cells. The RBARC² model aims to merge cannabinoid-based treatment with regenerative molecular coding. This OSF project serves as the official open-access repository for documents, figures, references, and community feedback. Principal Investigator: Ángel Díaz Morgado Organization: RBARC² Foundation Website: https://reprogramcancer.org